
“Red Flags”: Case Report of Cardiac Amyloidosis with Significant Coronary Artery Disease
More Info
Loren D.C. Gabayeron, MD | Cesar Antonio V. Zulueta, MD | Carlo Cortez, MD | Christie Anne Pabelico, MD | Allen Richard Villanueva, MD | Marianne Aludino, MD | Czarina Mae Reyes, MD
Perpetual Help Medical Center-Las Pinas
Correspondence:
Loren D.C. Gabayeron, MD
Email: lorengabayeron15@gmail.com
CONFLICTS OF INTEREST: None
- McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M., et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42:3599–3726. doi: 10.1093/eurheartj/ehab368.
- Falk RH, Alexander KM, Liao R, Dorbala S., et al. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol 2016; 68:1323.
- Maleszewski JJ. Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol 2015; 24:343-350 [PMID: 26361138 DOI: 10.1016/j.carpath.2015.07.008]
- G. Merlini, A. Dispenzieri, V. Sanchorawala et al., “Systemic immunoglobulin light chain amyloidosis,” Nature Reviews Disease Primers, vol. 4, no. 1, 2018.
- Witteles RM, Bokhari S, Damy T, et al. Screening for transthyretin amyloid cardiomyopathy in everyday practice.JACC Heart Failure.2019;7:709–716.
- Donnelly JP and Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med 2017; 84: 12-26 [PMID: 29257735 DOI: 10.3949/ccjm.84.s3.02]
- M. Rosenzweig and H. Landau, “Light chain (AL) amyloidosis: update on diagnosis and management,” Journal of Hematology and Oncology, vol. 4, no. 1, 2011.
- D. Phelan, P. Collier and P. Thavendiranathan. “Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis,” Heart, vol. 98, no. 19, pp. 1442–1448, 2012.
- Theresa A McDonagh, Marco Metra, Marianna Adamo & Roy S Gardner, et al. ESC Scientific Document Group , 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages 3599–3726, https://doi.org/10.1093/eurheartj/ehab368
- Dohrn MF, Ihne S, Hegenbart U, et al. Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis. J Neurochem 2021; 156:802.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0
International License, which permits use, share — copy and redistribute the material in any medium or format,
adapt — remix, transform, and build upon the material, as long as you give appropriate credit,
provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner,
but not in any way that suggests the licensor endorses you or your use. You may not use the material for
commercial purposes. If you remix, transform, or build upon the material, you must distribute your
contributions under the same license as the original. You may not apply legal terms or technological
measures that legally restrict others from doing anything the license permits. The images or other
third party material in this article are included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons
license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license,
visit https://creativecommons.org/licenses/by-nc-sa/4.0/.